Interview with Suzanne Lindley
HTML-код
- Опубликовано: 17 фев 2015
- Interview with Suzanne Lindley, a long time survivor of advanced metastatic colorectal cancer and Co-founder and President of YES (www.beatlivertumors.org)
The views and opinions expressed here are those of the individual contributors alone and do not necessarily reflect the views of Sirtex Medical Limited, its clients, or staff.
The information on this service is provided is "as is" with all faults and without warranty of any kind, expressed or implied, including those of merchantability and fitness for a particular purpose, or arising from a course of dealing, usage or trade practice.
Sirtex Medical Ltd makes no warranties or representations regarding the accuracy or completeness of the information. All products or services and logo's contained on the Sirtex site are the trademarks, service marks, registered trademarks or registered service marks of their respective owners.
The contents of the Sirtex World Wide Web site are protected by the copyright laws of Australia. No portion may be reproduced in any form, or by any means, without the prior written consent of Sirtex Medical Ltd.
Indication
SIR-Spheres microspheres are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy (IHAC) of FUDR (Floxuridine).
Important Safety Information
Almost all treatments and drugs produce unwanted side effects. Most side effects following a Selective Internal Radiation Therapy (SIRT) procedure are minor, but a small number can be serious. Every patient is different in how he or she reacts to a treatment. Many patients experience abdominal pain or tightness in their abdomen, nausea and loss of appetite which normally subsides within a week. Patients also develop a mild fever that may last for up to a week, and fatigue which may last for several weeks.
In rare instances, a small number of microspheres may inadvertently reach other organs in the body, such as the gallbladder, stomach, intestine, lung, or pancreas. If SIR-Spheres microspheres reach these organs, they may cause inflammation and potentially ulceration. These complications are rare, but if they do occur they may require additional medical treatment.
Please contact your health care professional about your condition and additional information concerning SIR-Spheres microspheres.
www.sirtex.com/risk